title: The role of established and emerging risk factors in peripheral vascular graft occlusion.
abstract: Several studies have evaluated the association between established as well as emerging vascular risk factors with peripheral graft occlusion. There is evidence for a link between the risk for graft occlusion and total serum cholesterol, low-density lipoprotein cholesterol and triglyceride levels. The overall effect of smoking shows a 2.35-fold increase in risk of graft failure. Studies involving diabetic patients undergoing peripheral bypass may have failed to detect higher occlusion rates, possibly due to increased morbidity and mortality as well as higher amputation rates even if the graft is patent. Both antiplatelet agents and anticoagulation seem to be effective in the prevention of graft occlusion. Unconvincing data have been published with regards to the effect of hypertension on graft patency. Emerging factors such as fibrinogen, lipoprotein (a), C-reactive protein and homocysteine levels should also be considered when assessing the risk of graft occlusion. More research is needed to prevent graft occlusion due to the obvious clinical relevance, quality of life and cost issues.
authors.affiliation: Department of Clinical Biochemistry, Royal Free Hospital and Royal Free University College Medical School, London, UK.
authors.forename: E M
authors.initials: EM
authors.lastname: Fatourou
authors.forename: K I
authors.initials: KI
authors.lastname: Paraskevas
authors.forename: A M
authors.initials: AM
authors.lastname: Seifalian
authors.forename: G
authors.initials: G
authors.lastname: Hamilton
authors.forename: D P
authors.initials: DP
authors.lastname: Mikhailidis
mesh_terms: D002097:C-Reactive Protein / Q000378:metabolism; D002784:Cholesterol / Q000097:blood; D001026:Coronary Artery Bypass; D003920:Diabetes Mellitus; D005340:Fibrinogen / Q000378:metabolism; D006083:Graft Occlusion, Vascular / Q000209:etiology* / Q000517:prevention & control; D006710:Homocysteine / Q000097:blood; D006801:Humans; D006973:Hypertension; D017270:Lipoprotein(a) / Q000097:blood; D016491:Peripheral Vascular Diseases / Q000601:surgery; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012307:Risk Factors; D012907:Smoking; D014656:Vascular Surgical Procedures
chemical_list: D017270:Lipoprotein(a); D010975:Platelet Aggregation Inhibitors; D006710:Homocysteine; D005340:Fibrinogen; D002097:C-Reactive Protein; D002784:Cholesterol